BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Finocchiaro D, Gear JI, Fioroni F, Flux GD, Murray I, Castellani G, Versari A, Iori M, Grassi E. Uncertainty analysis of tumour absorbed dose calculations in molecular radiotherapy. EJNMMI Phys 2020;7:63. [PMID: 33044651 DOI: 10.1186/s40658-020-00328-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Uribe C, Peterson A, Van B, Fedrigo R, Carlson J, Sunderland J, Frey E, Dewaraja YK. An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 1: Design and Early Results of the SNMMI Dosimetry Challenge. J Nucl Med 2021;62:36S-47S. [PMID: 34857620 DOI: 10.2967/jnumed.121.262748] [Reference Citation Analysis]
2 Liberini V, Rampado O, Gallio E, De Santi B, Ceci F, Dionisi B, Thuillier P, Ciuffreda L, Piovesan A, Fioroni F, Versari A, Molinari F, Deandreis D. 68Ga-DOTATOC PET/CT-Based Radiomic Analysis and PRRT Outcome: A Preliminary Evaluation Based on an Exploratory Radiomic Analysis on Two Patients. Front Med (Lausanne) 2020;7:601853. [PMID: 33575262 DOI: 10.3389/fmed.2020.601853] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xu L, Meng Q, Yao X, Yang R, Zhang P, Li R, Wang F. Dosimetry of 177Lu-DOTATOC first circle treatment in patients with advanced metastatic neuroendocrine tumors: A pilot study in China. Appl Radiat Isot 2022;179:109975. [PMID: 34741954 DOI: 10.1016/j.apradiso.2021.109975] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Völter F, Mittlmeier L, Gosewisch A, Brosch-Lenz J, Gildehaus FJ, Zacherl MJ, Beyer L, Stief CG, Holzgreve A, Rübenthaler J, Cyran CC, Böning G, Bartenstein P, Todica A, Ilhan H. Correlation of an Index-Lesion-Based SPECT Dosimetry Method with Mean Tumor Dose and Clinical Outcome after 177Lu-PSMA-617 Radioligand Therapy. Diagnostics (Basel) 2021;11:428. [PMID: 33802417 DOI: 10.3390/diagnostics11030428] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Piwowarska-bilska H, Kurkowska S, Birkenfeld B. Individualization of Radionuclide Therapies: Challenges and Prospects. Cancers 2022;14:3418. [DOI: 10.3390/cancers14143418] [Reference Citation Analysis]